Gilead Sciences, Inc. 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-19 4:15 pm Purchase |
2024-12-18 | 13G | Xilio Therapeutics, Inc. XLO |
GILEAD SCIENCES INC GILD |
9,105,451 19.900% |
1,759,978 (+23.96%) |
Filing |
| 2024-04-05 4:31 pm Purchase |
2024-03-27 | 13G | Xilio Therapeutics, Inc. XLO |
GILEAD SCIENCES INC GILD |
7,345,473 19.900% |
7,345,473 (New Position) |
Filing |